Cargando…

A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India

BACKGROUND & OBJECTIVES: One-fifth of the world's new tuberculosis (TB) cases and two-thirds of cases in the South East Asian region occur in India. Molecular typing of Mycobacterium tuberculosis isolates has greatly facilitated to understand the transmission of TB. This study was aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Anamika, Kulkarni, Savita, Rastogi, Nalin, Anupurba, Shampa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165002/
https://www.ncbi.nlm.nih.gov/pubmed/25109724
_version_ 1782335040495026176
author Gupta, Anamika
Kulkarni, Savita
Rastogi, Nalin
Anupurba, Shampa
author_facet Gupta, Anamika
Kulkarni, Savita
Rastogi, Nalin
Anupurba, Shampa
author_sort Gupta, Anamika
collection PubMed
description BACKGROUND & OBJECTIVES: One-fifth of the world's new tuberculosis (TB) cases and two-thirds of cases in the South East Asian region occur in India. Molecular typing of Mycobacterium tuberculosis isolates has greatly facilitated to understand the transmission of TB. This study was aimed to investigate the molecular epidemiology of M. tuberculosis genotypes in Varanasi, north India, and their association with clinical presentation among patients with pulmonary TB. METHODS: M. tuberculosis isolates from 104 TB patients attending a tertiary referral hospital of north India were screened for susceptibility to isoniazid (INH), rifampicin (RIF), ethambutol (EMB) and streptomycin (STR) by proportion method and multiplex-allele-specific-polymerase chain reaction (MAS-PCR). These were genotyped by spoligotyping. The spoligotype patterns were compared with those in the international SITVIT2 spoligotyping database. RESULTS: Eighty three of 104 isolates were distributed in 38 SITs, of which SIT3366 was newly created within the present study. The mass of ongoing transmission with MDR-TB isolates in Varanasi, northern India, was linked to Beijing genotype followed by the CAS1_Delhi lineage. HIV-seropositive patients had a significantly higher proportion of clustered isolates than HIV-seronegative patients and compared with the wild type(wt) isolates, the isolates with katG315Thr mutation were considerably more likely to be clustered. INTERPRETATION & CONCLUSIONS: This study gives an insight into the M. tuberculosis genetic biodiversity in Varanasi, north India, the predominant spoligotypes and their impact on disease transmission. In this region of north India, TB is caused by a wide diversity of spoligotypes with predominance of four genotype lineages: Beijing, CAS, EAI and T. The Beijing genotype was the most frequent single spoligotype and strongly associated with multi drug resistant (MDR)-TB isolates. These findings may have important implications for control and prevention of TB in north India.
format Online
Article
Text
id pubmed-4165002
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-41650022014-10-28 A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India Gupta, Anamika Kulkarni, Savita Rastogi, Nalin Anupurba, Shampa Indian J Med Res Original Article BACKGROUND & OBJECTIVES: One-fifth of the world's new tuberculosis (TB) cases and two-thirds of cases in the South East Asian region occur in India. Molecular typing of Mycobacterium tuberculosis isolates has greatly facilitated to understand the transmission of TB. This study was aimed to investigate the molecular epidemiology of M. tuberculosis genotypes in Varanasi, north India, and their association with clinical presentation among patients with pulmonary TB. METHODS: M. tuberculosis isolates from 104 TB patients attending a tertiary referral hospital of north India were screened for susceptibility to isoniazid (INH), rifampicin (RIF), ethambutol (EMB) and streptomycin (STR) by proportion method and multiplex-allele-specific-polymerase chain reaction (MAS-PCR). These were genotyped by spoligotyping. The spoligotype patterns were compared with those in the international SITVIT2 spoligotyping database. RESULTS: Eighty three of 104 isolates were distributed in 38 SITs, of which SIT3366 was newly created within the present study. The mass of ongoing transmission with MDR-TB isolates in Varanasi, northern India, was linked to Beijing genotype followed by the CAS1_Delhi lineage. HIV-seropositive patients had a significantly higher proportion of clustered isolates than HIV-seronegative patients and compared with the wild type(wt) isolates, the isolates with katG315Thr mutation were considerably more likely to be clustered. INTERPRETATION & CONCLUSIONS: This study gives an insight into the M. tuberculosis genetic biodiversity in Varanasi, north India, the predominant spoligotypes and their impact on disease transmission. In this region of north India, TB is caused by a wide diversity of spoligotypes with predominance of four genotype lineages: Beijing, CAS, EAI and T. The Beijing genotype was the most frequent single spoligotype and strongly associated with multi drug resistant (MDR)-TB isolates. These findings may have important implications for control and prevention of TB in north India. Medknow Publications & Media Pvt Ltd 2014-06 /pmc/articles/PMC4165002/ /pubmed/25109724 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Gupta, Anamika
Kulkarni, Savita
Rastogi, Nalin
Anupurba, Shampa
A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India
title A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India
title_full A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India
title_fullStr A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India
title_full_unstemmed A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India
title_short A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India
title_sort study of mycobacterium tuberculosis genotypic diversity & drug resistance mutations in varanasi, north india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165002/
https://www.ncbi.nlm.nih.gov/pubmed/25109724
work_keys_str_mv AT guptaanamika astudyofmycobacteriumtuberculosisgenotypicdiversitydrugresistancemutationsinvaranasinorthindia
AT kulkarnisavita astudyofmycobacteriumtuberculosisgenotypicdiversitydrugresistancemutationsinvaranasinorthindia
AT rastoginalin astudyofmycobacteriumtuberculosisgenotypicdiversitydrugresistancemutationsinvaranasinorthindia
AT anupurbashampa astudyofmycobacteriumtuberculosisgenotypicdiversitydrugresistancemutationsinvaranasinorthindia
AT guptaanamika studyofmycobacteriumtuberculosisgenotypicdiversitydrugresistancemutationsinvaranasinorthindia
AT kulkarnisavita studyofmycobacteriumtuberculosisgenotypicdiversitydrugresistancemutationsinvaranasinorthindia
AT rastoginalin studyofmycobacteriumtuberculosisgenotypicdiversitydrugresistancemutationsinvaranasinorthindia
AT anupurbashampa studyofmycobacteriumtuberculosisgenotypicdiversitydrugresistancemutationsinvaranasinorthindia